about
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.Defining and analyzing retention-in-care among pregnant and breastfeeding HIV-infected women: unpacking the data to interpret and improve PMTCT outcomes.Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.Couple-oriented prenatal HIV counseling for HIV primary prevention: an acceptability study.Intimate partner sexual and physical violence among women in Togo, West Africa: prevalence, associated factors, and the specific role of HIV infectionEffectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest).Factors Associated with HIV Testing History among Pregnant Women and Their Partners in Georgia: The ANRS 12127 Prenahtest Trial.A qualitative study on knowledge, perceptions, and attitudes of mothers and health care providers toward pneumococcal conjugate vaccine in Bandung, West Java, Indonesia.Couple-centred testing and counselling for HIV serodiscordant heterosexual couples in sub-Saharan Africa.Willingness to use the Internet to seek information on HIV prevention and care among men who have sex with men in Ho Chi Minh City, Vietnam.Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literatureUptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised TrialAccess to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South AfricaChildren and HIV/AIDS: from research to policy and action in resource-limited settingsMen, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa."It is better to die": experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial).Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe.Patterns of Attendance at Mother Support Groups in Zimbabwe. The EPAZ Trial (2014-2016).Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa.HIV risk perception among pregnant women in western India: need for reducing vulnerabilities rather than improving knowledge!Increasing HIV testing among male partners.Strengthening universal HIV 'test-and-treat' approaches with social science research.Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience.Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa.Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic.Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers.Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa.Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.[A decade of child health research in developing countries].Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for aThe impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)HIV Ascertainment through Repeat Home-based Testing in the Context of a Treatment as Prevention Trial (ANRS 12249 TasP) in Rural South AfricaLinkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort studyStrategies of HIV Prevention in Low and Middle-Income CountriesRetention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial)
P50
Q30625366-54BFD1D4-D4ED-4D4C-AFF3-AC3E290ED8FBQ30859773-32AD3BFA-8DEA-4039-8ABA-94B730C76FEDQ31010333-E2F51BD6-1A65-458E-B0E7-CB6AC25EAC2BQ33559057-95C8850C-8ABB-4B94-86DE-C55D2E5CEC61Q33676824-006695E2-28CA-42FA-A0C4-F82E4D9DECEBQ33818426-DCC251B1-3813-4127-B917-C13450F4CB48Q33998566-CB3F542E-63EE-4EF6-A568-6C41FFF86AACQ34330076-5988AF68-AC85-45D7-AD95-4756CE232BC4Q34547721-B3D6CA50-F147-4BD5-88FB-7E7F444E9969Q34886820-B8DEBC3E-537C-4C91-8468-732E61FE5731Q34971190-8F0A6ED3-2F6F-46E4-A102-F2618CF058C4Q35778800-37740167-3AD5-4FCE-9F5A-B3DB68DF1F98Q36098544-366775BD-9255-4FF7-9A27-A1EEB78667DFQ36965839-4C9B4A85-6263-47BF-96FE-C7FA5EA474E7Q37143745-F40F81C4-1200-4F9B-9286-09DF9D3998F6Q37395460-8FDC2C6E-5FA2-4589-9AFB-CF81A75853A9Q37395464-3926E74E-B85B-467A-A9D2-8999548341B8Q37395475-0E11CF8E-0056-46F6-800F-5F4B35A1C822Q37611746-CDDBC3C4-3CE5-47C4-9260-2FEEA3D1DFA8Q38401077-3E6ADA4E-40F3-4C94-88B5-42D0365BBBF7Q38789576-C1086F06-F6CE-42F2-B6B3-728C5A9368A9Q38789580-63F2F0AF-950C-4F6B-AB4C-A76C8706142FQ40612148-4F319E10-966E-4479-B99D-0EB936947714Q42241229-FFF771D6-F96E-40ED-8FC7-2F54DEF211D5Q42277805-2528DEB2-AF95-4088-B2EE-859CDA3F4E7EQ42951419-8311F34E-1619-4252-B281-C260F522CA51Q44959754-DAD13841-30F0-4AC3-AE7F-652B5D29FE86Q46570650-52FC2BAF-420E-4EB5-B471-AAC222676226Q46724030-A38E1AC8-1302-4F8A-BCDD-FBFA791B2917Q47165580-937E5379-1090-46E6-9BF1-D4F688C0490BQ47191055-AD37ABD7-0B64-41FD-83D5-FEF80C3DDB0CQ47589510-E668129E-0EE0-494B-B346-78BB32EB1E96Q47968433-848742A6-1DD0-46C2-9C6C-28FF7BAB842AQ55546871-43FEF753-4F12-4009-B08B-DEFCBAC02511Q56833602-EED0617F-0861-45DC-A5BF-000982D61457Q56833624-6E32EBF5-ACA7-4D59-83F2-C88FCD8CB404Q60306178-5719A59D-F201-4256-8587-C3CD75C335BBQ60720413-CF5A69F4-208C-4EA1-A120-D03D2FE4E539Q64051734-AC07EC8F-67F6-471B-ADAB-CA8ECC148055
P50
name
Joanna Orne-Gliemann
@en
Joanna Orne-Gliemann
@nl
type
label
Joanna Orne-Gliemann
@en
Joanna Orne-Gliemann
@nl
prefLabel
Joanna Orne-Gliemann
@en
Joanna Orne-Gliemann
@nl